StonvexLoading…
StonvexStonvexStonvexCore line items from DAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $63.36B | $61.64B | $58.05B | $50.58B |
Operating Income | $5.82B | $6.00B | $5.52B | $3.66B |
Net Income | $5.00B | $3.46B | $4.61B | $1.32B |
EPS (Diluted) | $7.66 | $5.33 | $7.17 | $2.06 |
Total Assets | $81.32B | $75.37B | $73.64B | $72.29B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.31B | $3.07B | $2.74B | $3.27B |
Free Cash Flow OCF − CapEx | $3.84B | $2.88B | $1.14B | $-3.00M |
Shares Outstanding | 654.00M | 648.00M | 643.00M | 641.00M |